{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:09:23Z","timestamp":1791378563371,"version":"4.3.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K14669"],"award-info":[{"award-number":["23K14669"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007655","name":"Aichi Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11060-023-04358-8","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T17:01:46Z","timestamp":1686157306000},"page":"385-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases"],"prefix":"10.1007","volume":"163","author":[{"given":"Naoya","family":"Nagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurika","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Naganawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"4358_CR1","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/cncr.10541","volume":"94","author":"LJ Schouten","year":"2002","unstructured":"Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698\u20132705","journal-title":"Cancer"},{"key":"4358_CR2","unstructured":"NCCN guidelines available at http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp (Accessed on January 10, 2023). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf. Accessed 10 Jan 2023"},{"key":"4358_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","volume":"12","author":"V Gondi","year":"2022","unstructured":"Gondi V, Bauman G, Bradfield L et al (2022) Radiation therapy for brain metastases: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol 12:265\u2013282","journal-title":"Pract Radiat Oncol"},{"key":"4358_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H et al (2022) Treatment for brain metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol 40:492\u2013516","journal-title":"J Clin Oncol"},{"key":"4358_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009454.pub2","author":"YY Soon","year":"2014","unstructured":"Soon YY, Tham IWK, Lim KH et al (2014) Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009454.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4358_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases. JAMA 316:401","journal-title":"JAMA"},{"key":"4358_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29:134\u2013141","journal-title":"J Clin Oncol"},{"key":"4358_CR8","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665\u20131672","journal-title":"Lancet"},{"key":"4358_CR9","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483\u20132491","journal-title":"JAMA"},{"key":"4358_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037\u20131044","journal-title":"Lancet Oncol"},{"key":"4358_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","volume":"15","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387\u2013395","journal-title":"Lancet Oncol"},{"key":"4358_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijrobp.2017.04.037","volume":"99","author":"M Yamamoto","year":"2017","unstructured":"Yamamoto M, Serizawa T, Higuchi Y et al (2017) A multi-institutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901 Study Update): irradiation-related complications and long-term maintenance of mini-mental state examination scores. Int J Radiat Oncol Biol Phys 99:31\u201340","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4358_CR13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ijrobp.2019.03.052","volume":"104","author":"RT Hughes","year":"2019","unstructured":"Hughes RT, Masters AH, McTyre ER et al (2019) Initial SRS for patients with 5 to 15 brain metastases: results of a multi-institutional experience. Int J Radiat Oncol Biol Phys 104:1091\u20131098","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4358_CR14","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ijrobp.2020.07.2108","volume":"108","author":"J Li","year":"2020","unstructured":"Li J, Ludmir EB, Wang Y et al (2020) Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4\u201315 brain metastases: a phase III randomized controlled trial. Int J Radiat Oncol Biol Phys 108:S21\u2013S22","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4358_CR15","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.22.00520","volume":"40","author":"N Ramakrishna","year":"2022","unstructured":"Ramakrishna N, Anders CK, Lin NU et al (2022) Management of advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: ASCO Guideline Update. J Clin Oncol 40:2636\u20132655","journal-title":"J Clin Oncol"},{"key":"4358_CR16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","volume":"100","author":"L Chen","year":"2018","unstructured":"Chen L, Douglass J, Kleinberg L et al (2018) Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma. Int J Radiat Oncol Biol Phys 100:916\u2013925","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4358_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11060-016-2265-z","volume":"131","author":"A Geraud","year":"2017","unstructured":"Geraud A, Xu HP, Beuzeboc P, Kirova YM (2017) Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer. J Neurooncol 131:69\u201372","journal-title":"J Neurooncol"},{"key":"4358_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1283461","volume":"6","author":"T Skrepnik","year":"2017","unstructured":"Skrepnik T, Sundararajan S, Cui H, Stea B (2017) Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab. Oncoimmunology 6:e1283461","journal-title":"Oncoimmunology"},{"key":"4358_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijrobp.2020.01.043","volume":"108","author":"DA Pomeranz Krummel","year":"2020","unstructured":"Pomeranz Krummel DA, Nasti TH, Izar B et al (2020) Impact of sequencing radiation therapy and immune checkpoint inhibitors in the treatment of melanoma brain metastases. Int J Radiat Oncol Biol Phys 108:157\u2013163","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4358_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cllc.2021.06.009","volume":"23","author":"Y Yang","year":"2022","unstructured":"Yang Y, Deng L, Yang Y et al (2022) Efficacy and safety of combined brain radiotherapy and immunotherapy in non-small-cell lung cancer with brain metastases: a systematic review and meta-analysis. Clin Lung Cancer 23:95\u2013107","journal-title":"Clin Lung Cancer"},{"key":"4358_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/neuonc\/noz046","volume":"21","author":"R Kotecha","year":"2019","unstructured":"Kotecha R, Kim JM, Miller JA et al (2019) The impact of sequencing PD-1\/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis. Neuro Oncol 21:1060\u20131068","journal-title":"Neuro Oncol"},{"key":"4358_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.wneu.2019.04.032","volume":"130","author":"R Ramakrishna","year":"2019","unstructured":"Ramakrishna R, Formenti S (2019) Radiosurgery and immunotherapy in the treatment of brain metastases. World Neurosurg 130:615\u2013622","journal-title":"World Neurosurg"},{"key":"4358_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10555-020-09949-9","volume":"40","author":"P-Y Borius","year":"2021","unstructured":"Borius P-Y, R\u00e9gis J, Carpentier A et al (2021) Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and\/or immunotherapy) in brain metastases: a systematic review. Cancer Metastasis Rev 40:341\u2013354","journal-title":"Cancer Metastasis Rev"},{"key":"4358_CR24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ijrobp.2018.02.175","volume":"101","author":"E Schapira","year":"2018","unstructured":"Schapira E, Hubbeling H, Yeap BY et al (2018) Improved overall survival and locoregional disease control with concurrent PD-1 pathway inhibitors and stereotactic radiosurgery for lung cancer patients with brain metastases. Int J Radiat Oncol Biol Phys 101:624\u2013629","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4358_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153682","author":"R Tonse","year":"2021","unstructured":"Tonse R, Tom MC, Mehta MP et al (2021) Integration of systemic therapy and stereotactic radiosurgery for brain metastases. Cancers. https:\/\/doi.org\/10.3390\/cancers13153682","journal-title":"Cancers"},{"key":"4358_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11060-022-04132-2","volume":"160","author":"Y Koide","year":"2022","unstructured":"Koide Y, Nagai N, Miyauchi R et al (2022) Radiotherapy or systemic therapy versus combined therapy in patients with brain metastases: a propensity-score matched study. J Neurooncol 160:191\u2013200","journal-title":"J Neurooncol"},{"key":"4358_CR27","first-page":"397","volume":"81","author":"Y Koide","year":"2019","unstructured":"Koide Y, Tomita N, Adachi S et al (2019) Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm. Nagoya J Med Sci 81:397\u2013406","journal-title":"Nagoya J Med Sci"},{"key":"4358_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyad026","author":"Y Koide","year":"2023","unstructured":"Koide Y, Nagai N, Miyauchi R et al (2023) Recent trends of characteristics and treatments in adults with newly diagnosed brain metastases. Jpn J Clin Oncol. https:\/\/doi.org\/10.1093\/jjco\/hyad026","journal-title":"Jpn J Clin Oncol"},{"key":"4358_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jjco\/hyac034","volume":"52","author":"J Eba","year":"2022","unstructured":"Eba J, Nakamura K (2022) Overview of the ethical guidelines for medical and biological research involving human subjects in Japan. Jpn J Clin Oncol 52:539\u2013544","journal-title":"Jpn J Clin Oncol"},{"key":"4358_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/10543406.2010.550701","volume":"22","author":"S-H Jung","year":"2012","unstructured":"Jung S-H, Chow S-C (2012) On sample size calculation for comparing survival curves under general hypothesis testing. J Biopharm Stat 22:485\u2013495","journal-title":"J Biopharm Stat"},{"key":"4358_CR31","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J et al (2020) Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38:3773\u20133784","journal-title":"J Clin Oncol"},{"key":"4358_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.03.020","volume":"114","author":"PW Sperduto","year":"2022","unstructured":"Sperduto PW, De B, Li J et al (2022) Graded prognostic assessment (GPA) for patients with lung cancer and brain metastases: initial report of the small cell lung cancer GPA and update of the non-small cell lung cancer gpa including the effect of programmed death ligand 1 and other prognostic factors. Int J Radiat Oncol Biol Phys 114:60\u201374","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4358_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.radonc.2021.03.022","volume":"159","author":"J Kraft","year":"2021","unstructured":"Kraft J, van Timmeren JE, Mayinger M et al (2021) Distance to isocenter is not associated with an increased risk for local failure in LINAC-based single-isocenter SRS or SRT for multiple brain metastases. Radiother Oncol 159:168\u2013175","journal-title":"Radiother Oncol"},{"key":"4358_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13014-018-0985-2","volume":"13","author":"R Ruggieri","year":"2018","unstructured":"Ruggieri R, Naccarato S, Mazzola R et al (2018) Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique. Radiat Oncol 13:38","journal-title":"Radiat Oncol"},{"key":"4358_CR35","doi-asserted-by":"crossref","unstructured":"Reungwetwattana T, Nakagawa K, Cho BC, et al (2018) CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer. J Clin Oncol JCO2018783118","DOI":"10.1200\/JCO.2018.78.3118"},{"key":"4358_CR36","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.21037\/jtd.2019.03.76","volume":"11","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Guo H, Lu Y et al (2019) Anaplastic lymphoma kinase inhibitors in non-small cell lung cancer patients with brain metastases: a meta-analysis. J Thorac Dis 11:1397\u20131409","journal-title":"J Thorac Dis"},{"key":"4358_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijrobp.2014.05.047","volume":"90","author":"AA Garsa","year":"2014","unstructured":"Garsa AA, Badiyan SN, DeWees T et al (2014) Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases. Int J Radiat Oncol Biol Phys 90:407\u2013413","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4358_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/ajco.13309","volume":"16","author":"PH Ko","year":"2020","unstructured":"Ko PH, Kim HJ, Lee JS, Kim WC (2020) Tumor volume and sphericity as predictors of local control after stereotactic radiosurgery for limited number (1\u20134) brain metastases from nonsmall cell lung cancer. Asia Pac J Clin Oncol 16:165\u2013171","journal-title":"Asia Pac J Clin Oncol"},{"key":"4358_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jocn.2016.03.037","volume":"33","author":"S Suzuki","year":"2016","unstructured":"Suzuki S, Inoue T, Ishido K (2016) Factors influencing local tumor control after Gamma Knife radiosurgery for intracranial metastases from breast cancer. J Clin Neurosci 33:154\u2013158","journal-title":"J Clin Neurosci"},{"issue":"Suppl","key":"4358_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/2010.8.GKS10994","volume":"113","author":"WS Chang","year":"2010","unstructured":"Chang WS, Kim HY, Chang JW et al (2010) Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg 113(Suppl):73\u201378","journal-title":"J Neurosurg"},{"key":"4358_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3171\/2012.4.JNS11870","volume":"117","author":"R Grandhi","year":"2012","unstructured":"Grandhi R, Kondziolka D, Panczykowski D et al (2012) Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases. J Neurosurg 117:237\u2013245","journal-title":"J Neurosurg"},{"key":"4358_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3171\/2013.4.JNS121751","volume":"119","author":"P Rava","year":"2013","unstructured":"Rava P, Leonard K, Sioshansi S et al (2013) Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery: Clinical article. J Neurosurg 119:457\u2013462","journal-title":"J Neurosurg"},{"key":"4358_CR43","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3171\/2013.2.JNS121213","volume":"118","author":"DJ Salvetti","year":"2013","unstructured":"Salvetti DJ, Nagaraja TG, McNeill IT et al (2013) Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article. J Neurosurg 118:1250\u20131257","journal-title":"J Neurosurg"},{"issue":"Suppl","key":"4358_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3171\/2014.8.GKS141421","volume":"121","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Kawabe T, Sato Y et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2\u20139 versus 10 or more tumors. J Neurosurg 121(Suppl):16\u201325","journal-title":"J Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04358-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T08:07:47Z","timestamp":1688544467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04358-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4358"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04358-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"YK has a speaker bureau from Hitachi Co., and has received research funding from Japan Society for the Promotion of Science (JSPS, Grant Number 23K14669, 20K16402), and Aichi Cancer Research Foundation. TK has speaker bureaus from Hitachi Co., Bristle Myers Squibb., Accuray Co., Elekta Co., Ono Pharmaceutical Co., AstraZeneca Co., Taiho Pharmaceutical Co., Canon Co., and Janssen Pharmaceutical Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}